ClinicalTrials.Veeva

Menu

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

C

Catalysis SL

Status and phase

Completed
Phase 3
Phase 2

Conditions

Overweight
Obesity

Treatments

Dietary Supplement: Obex
Drug: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT01934036
HOPE_TRIAL1

Details and patient eligibility

About

The aim of the study is to evaluate the effects of a dietary supplement (Obex®) on anthropometric and physiological variables in Spanish women between 35 and 60 years who are overweight or obese.

Full description

The nutritional supplement consists of natural plant extracts such as Caralluma fimbriata, Phaseolus vulgaris, Acai Berry and other antiobesity agents: ornithine, carnitine fumarate, essential fatty acids and certain amino acids, vitamins and minerals.

Enrollment

92 patients

Sex

Female

Ages

35 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women aged between 35 and 60 years.
  • Body Mass Index (BMI) greater than 27 kg/m² and lower than 35 kg/m²
  • Ability to provide informed consent

Exclusion criteria

  • Presence of any endocrine, hepatic, renal or cardiovascular disease.
  • History of bariatric surgery
  • Pregnancy or lactation
  • Concomitant disease with reduced life expectancy
  • Severe psychiatric conditions
  • Drug dependence

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

92 participants in 2 patient groups, including a placebo group

Obex, a nutritional supplement
Experimental group
Description:
Obex will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during two months. Patients will be recommended to comply with a healthy lifestyle through diet and exercise.
Treatment:
Dietary Supplement: Obex
Placebo
Placebo Comparator group
Description:
Placebo will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during two months. Patients will be recommended to comply with a healthy lifestyle through diet and exercise.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems